Reply to: Attention-deficit/hyperactivity disorder and solar irradiance: A cloudy perspective

Martijn Arns; Kristiaan B. Van Der Heijden; L. Eugene Arnold; James M. Swanson; J. Leon Kenemans

doi:10.1016/j.biopsych.2013.09.033

Reply to: Attention-deficit/hyperactivity disorder and solar irradiance: A cloudy perspective

Martijn Arns
, Kristiaan B. Van Der Heijden
, L. Eugene Arnold
, James M. Swanson
, J. Leon Kenemans

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e21-e23
Journal	Biological Psychiatry
Volume	76
Issue number	8
DOIs	https://doi.org/10.1016/j.biopsych.2013.09.033
State	Published - Oct 15 2014

Access to Document

10.1016/j.biopsych.2013.09.033

Cite this

@article{f7987dca827b4f9786d6a898a105e222,

title = "Reply to: Attention-deficit/hyperactivity disorder and solar irradiance: A cloudy perspective",

author = "Martijn Arns and \{Van Der Heijden\}, \{Kristiaan B.\} and Arnold, \{L. Eugene\} and Swanson, \{James M.\} and Kenemans, \{J. Leon\}",

note = "Funding Information: LEA has received research funding (to the university) or advisory board honoraria from AstraZeneca, Biomarin, CureMark, Forest, Lilly, Novartis, Noven, Roche, Seaside Therapeutics, Shire, and Tris Pharma and travel support from Noven. JMS has received research support, advisory board honoria, or travel support from Johnson \& Johnson, Novartis, UCB, Janssen, Biomarin, Shire, and Noven. MA, KvdH and JLK report no biomedical financial interests or potential conflicts of interest. ",

year = "2014",

month = oct,

day = "15",

doi = "10.1016/j.biopsych.2013.09.033",

language = "English",

volume = "76",

pages = "e21--e23",

journal = "Biological Psychiatry",

issn = "0006-3223",

number = "8",

}

TY - JOUR

T1 - Reply to

T2 - Attention-deficit/hyperactivity disorder and solar irradiance: A cloudy perspective

AU - Arns, Martijn

AU - Van Der Heijden, Kristiaan B.

AU - Arnold, L. Eugene

AU - Swanson, James M.

AU - Kenemans, J. Leon

N1 - Funding Information: LEA has received research funding (to the university) or advisory board honoraria from AstraZeneca, Biomarin, CureMark, Forest, Lilly, Novartis, Noven, Roche, Seaside Therapeutics, Shire, and Tris Pharma and travel support from Noven. JMS has received research support, advisory board honoria, or travel support from Johnson & Johnson, Novartis, UCB, Janssen, Biomarin, Shire, and Noven. MA, KvdH and JLK report no biomedical financial interests or potential conflicts of interest.

PY - 2014/10/15

Y1 - 2014/10/15

UR - https://www.scopus.com/pages/publications/84922223069

U2 - 10.1016/j.biopsych.2013.09.033

DO - 10.1016/j.biopsych.2013.09.033

M3 - Letter

C2 - 24252358

AN - SCOPUS:84922223069

SN - 0006-3223

VL - 76

SP - e21-e23

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 8

ER -

Reply to: Attention-deficit/hyperactivity disorder and solar irradiance: A cloudy perspective

Access to Document

Other files and links

Cite this